The company's purpose is the development and marketing of medical devices that improve or replace cardiac function, particularly through the use of nanotechnology and smart materials, as part of the development of an atrial support system for patients with heart failure. The company may engage in any financial, commercial, and industrial activity directly or indirectly related to its purpose; create branches or subsidiaries in Switzerland and abroad; participate in all enterprises having a direct or indirect relationship with its purpose; grant loans or guarantees to associates or third parties if it serves its interests.